Counterfeit/Copy Drugs: Patients Safety in the Heart
Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey
Thalass. Rep. 2011, 1(s2), e28; https://doi.org/10.4081/thal.2011.s2.e28
Submission received: 1 December 2011
/
Revised: 15 December 2011
/
Accepted: 27 December 2011
/
Published: 30 December 2011
Abstract
Some studies demonstrate that a large proportion of copy drugs contain lower levels of active substances and higher impurity levels than reference drugs. The number of copy drugs failing to meet internationally recognised quality criteria consequences of patients receiving lower doses of active substances than expected. In addition, possible clinical effect of impurities must be considered. Counterfeiting of drugs exhibits a significant and growing threat to human health and public safety.
Keywords:
counterfeit drugs; copy drugs; internet-sourced drugs; genuine drugs
Share and Cite
MDPI and ACS Style
Capan, Y. Counterfeit/Copy Drugs: Patients Safety in the Heart. Thalass. Rep. 2011, 1, e28. https://doi.org/10.4081/thal.2011.s2.e28
AMA Style
Capan Y. Counterfeit/Copy Drugs: Patients Safety in the Heart. Thalassemia Reports. 2011; 1(s2):e28. https://doi.org/10.4081/thal.2011.s2.e28
Chicago/Turabian StyleCapan, Y. 2011. "Counterfeit/Copy Drugs: Patients Safety in the Heart" Thalassemia Reports 1, no. s2: e28. https://doi.org/10.4081/thal.2011.s2.e28
